http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NL-2028806-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70fbe08b7c540157200696115221f654 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-00022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-00034 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate | 2021-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2270b704cdf3e43d96b23983a982e9b |
| publicationDate | 2022-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NL-2028806-B1 |
| titleOfInvention | Tilv-2 protein or gene encoding tilv-2 protein in preparation of subunit vaccine against tilapia lake virus |
| abstract | The present invention provides use of TILV-2 protein, a gene encoding TILV-2 protein, a recombinant plasmid containing the gene or recombinant bacteria containing the gene in preparation of subunit vaccine against Tilapia Lake virus. The present invention belongs to the technical field of vaccine engineering. The present invention uses TILV- 2 protein as the immunogenic protein to prepare the subunit vaccine against Tilapia Lake virus, fills the gap in the research of subunit vaccine against Tilapia Lake virus, effectively avoids the biological safety risks caused by using whole pathogen to produce vaccines, and facilitates the Tilapia large-scale production of vaccine against Lake virus. It has been verified that a protection rate was up to 72% after immunizing the Tilapia with the subunit vaccine against Tilapia Lake virus prepared by the method of the present invention. |
| priorityDate | 2021-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 288.